http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013203614-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8a219eb07af9fcec1e268bf3966e735 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-015 |
| filingDate | 2013-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e10ae92aeb2fa8d9f4d5ec23222071da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2105487a6809a35574baa0f43290b1e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76849a0332e1cdf90cc6fe55f5b8022a |
| publicationDate | 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013203614-A2 |
| titleOfInvention | Purified plasmodium and vaccine compositions - D1 |
| abstract | H:br\Intevovcn\NRPonbl\DCC\RBR\5064796_ L.DOC-10/04/2013 Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided WO 2010/083111 PCT/US2010/020564 x moss s 2% MOs xN y-k SUBSTITUTE SHEET (RULE 26) |
| priorityDate | 2009-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.